Tocilizumab in COVID-19 therapy: who benefits, and how?

Avidan U. Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)299-300
Number of pages2
JournalThe Lancet
Volume398
Issue number10297
DOIs
StatePublished - 24 Jul 2021
Externally publishedYes

Cite this